Overview of the Ovarian Cancer Market:
Ovarian cancer is one of the most frequently diagnosed cancers among women. The ovaries, a pair of molars, are usually the site where menstrual blood (lactated) is absorbed. In nearly all cases, ovarian cancer happens after the age of 40, and in most instances, it takes place after the age of 60. The most common type of ovarian cancer starts in epithelial cells, which are the flat, smooth cells that line most surfaces and most cavities in the human body. When these cells begin to grow abnormally – extending out of their places, enlarging in some areas, or spreading to other parts of the body – they become potential cancers.
“The ovarian cancer market was valued at $2.1 billion in 2020, and it is expected to grow to $6.3 billion in 2021 to 2028 with a CAGR of 13.9%, By Stratagem Market Insights”
The growing prevalence of ovarian cancer is a key factor driving the market growth of ovarian cancer drugs. According to the World Cancer Research Fund International, ovarian cancer is the 18th most common cancer worldwide. There were nearly 300,000 new cases in 2018. The increasing focus of manufacturers in developing novel therapeutics that are efficient and cost-effective is again contributing to market growth. The growing geriatric population as ovarian cancer is more prevalent among elderly women is expected to positively impact the market growth. Also, the growing development of chemotherapies for the management of ovarian cancer is further expected to foster market growth.
Request for a Sample Report at – https://www.stratagemmarketinsights.com/sample/41837
From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of cancer in the region coupled with the growing research and development for producing efficient therapies. According to the National Cancer Institute, around 1.2 percent of women will be diagnosed with ovarian cancer at some point during their lifetime. In 2017, there were an estimated 233,364 women living with ovarian cancer in the United States.
Key Developments:
- In April 2020, the Food and Drug Administration approved niraparib (ZEJULA, GlaxoSmithKline) for the treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.
- In May 2020, AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) in combination with bevacizumab has been approved in the US for the treatment of adult patients with an advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
- In July 2020, Cadila Pharmaceuticals announced the launch of Bevasizumab biosimilar for the domestic market. Bevacizumab biosimilar is a humanized monoclonal antibody, recommended in multiple indications and will be launched under the brand name Bevaro.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Ovarian Cancer Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Ovarian Cancer Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Bristol Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline plc
- Janssen Pharmaceuticals, Inc.
- Novogen, Inc.
- Genentech Inc.
- Aetera Zenteris Inc.
- Boehringer Ingelheim GmbH
- F. Hoffman-La Roche Ltd.
Contact us for customization in the report @ https://www.stratagemmarketinsights.com/quiry/41837
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Ovarian Cancer Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into: Epithelial Tumors, Germ Cell Tumors, Stromal Tumors
By Applications, the market is segmented into: Hospitals, Diagnostic Centers, Drug Stores, Online Pharmacies, Other End Users
Growth by Region:
The different section on regional segmentation gives the regional aspects of the worldwide Ovarian Cancer market. This chapter describes the regulatory structure that is likely to impact the complete market. It highlights the political landscape in the market and predicts its influence on the Ovarian Cancer market globally.
The global Ovarian Cancer market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), Middle East & Africa (South Africa, Saudi Arabia, and others).
Our key underpinning is the 4-Quadrant Framework that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
Most Frequently Questions Asked to Us:
- What are the current market size and compound annual growth rate (CAGR) of the market during the forecast period (2021-2028)?
- What are the major factors driving the market growth?
- What are the key factors hampering the growth of the market?
- Which are the major players operating in the market?
Major Points of Ovarian Cancer Market – Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ovarian Cancer Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Ovarian Cancer Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Ovarian Cancer Market
1.6.1 How the Covid-19 is Affecting the Ovarian Cancer Market
1.6.1.1 Ovarian Cancer Market Business Impact Assessment – Covid-19
1.6.2 Market Trends and Ovarian Cancer Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Ovarian Cancer Market Perspective (2015-2028)
2.2 Ovarian Cancer Market Growth Trends by Regions
2.2.1 Ovarian Cancer Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Ovarian Cancer Market Historic Market Share by Regions (2015-2021)
2.2.3 Ovarian Cancer Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Ovarian Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Ovarian Cancer Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
4 Breakdown Data by Type (2015-2028)
5 Ovarian Cancer Market Breakdown Data by Application (2015-2028)
.
.
.
.
13 Key Players Profiles
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Reasons to Purchase this Report:
- The trendy developments, market shares, and strategies that are employed by means of the essential market players
- The segment that is anticipated to dominate the market as properly as the segment which holds the highest CAGR in the forecast period
- Current and future of global Ovarian Cancer market outlook in the developed and rising markets
- Regions/countries that are anticipated to witness the quickest growth rates at some stage in the forecast period
Buy This Complete A Business Report With Discounted Price @ https://www.stratagemmarketinsights.com/cart/41837
About Us:
Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. We strive to offer sapient solutions, expert consultations, and tailored/customized solutions. Our team includes analysts that leverage their years of experience and expertise to create accurate and error-free reports. The domain-specific teams are constantly focused on tracking markets, aiding our clients to gain a competitive edge through high-quality market intelligence. We offer an array of services including, syndicated research, advisory and consulting research process outsourcing, and content management.
Contact Us:
Mr. Shah
Stratagem Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027 / JAPAN +815055391737
Email: sales@stratagemmarketinsights.com